Vasopressin for cardiac arrest increases chances of survivalBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7432.128-a (Published 15 January 2004) Cite this as: BMJ 2004;328:128
- Scott Gottlieb
- New York
People with refractory cardiac arrest are three times as likely to survive if they are given the antidiuretic hormone vasopressin than if they receive the standard emergency treatment, adrenaline (epinephrine).
The new findings are from a study of patients with cardiac arrest in Austria, Germany, and Switzerland.
The current international guidelines for coronary pulmonary resuscitation recommend the use of adrenaline during cardiac resuscitation and consider vasopressin only as a secondary alternative, because clinical data on treatment with vasopressin have been limited.
Researchers led by Volker Wenzel of the department of anaesthesiology and critical care medicine at Leopold-Franzens University, Innsbruck, Austria, randomly assigned adults who had had …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial